Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_02572
Species: Homo sapiens
Position : chr8:128172101-128172473
Year: 2025
Title: Selective Enhancer Dependencies in MYC-Intact and MYC-Rearranged Germinal Center B-cell Diffuse Large B-cell Lymphoma.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: diffuse large B-cell lymphoma
PMID:  40067173
MONDO: MONDO:0018905
Tissue: inguinal part of abdomen
Tissue Ontology ID: UBERON:0008337
Cell Source: BJAB
CVCL ID: CVCL_5711
Cell Type: B cell
Cell Ontology ID: CL:0000236
Experiment Type: Enhancer activity assay; TF binding assay; Functional perturbation assay
High Throughput Method: H3K27ac ChIP-seq; ATAC-seq; OCT2 BioChIP-seq (published dataset)
Low Throughput Method: Individual CRISPRi; qRT-PCR; Western blot
About Target Gene
Target gene : MYC
About TF
TF name : POU2F2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
POU2F2 BCR signaling pathway pid 70
POU2F2 RNA polymerase II transcribes snRNA genes reactome 70
POU2F2 Validated transcriptional targets of deltaNp63 isoforms pid 47
Enhancer Associated Network
Overlapping Enhancers (hg38) 7 found
Enhancer ID Position Tissue Cell Disease
E_03876 chr8:126650000-129950000 colon malignant cell NA
E_02496 chr8:128172101-128172473 lymph node germinal center B cell diffuse large B-cell lymphoma
E_02497 chr8:128172101-128172473 lymph node germinal center B cell diffuse large B-cell lymphoma
E_02498 chr8:128172101-128172473 lymph node germinal center B cell diffuse large B-cell lymphoma
E_02499 chr8:128172101-128172473 ascitic fluid germinal center B cell diffuse large B-cell lymphoma
E_02500 chr8:128172101-128172473 ascitic fluid germinal center B cell diffuse large B-cell lymphoma
E_02501 chr8:128172101-128172473 ascitic fluid germinal center B cell diffuse large B-cell lymphoma
Expression of Target Genes for the Enhancer